Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/32316
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Flórez, ID | - |
dc.contributor.author | Velásquez-Salazar, P | - |
dc.contributor.author | Martínez, JC | - |
dc.contributor.author | Linkins, L | - |
dc.contributor.author | Abdelkader, W | - |
dc.contributor.author | Iorio, A | - |
dc.contributor.author | Lavis, J | - |
dc.contributor.author | Patiño-Lugo, DF | - |
dc.date.accessioned | 2025-09-17T18:44:15Z | - |
dc.date.available | 2025-09-17T18:44:15Z | - |
dc.date.issued | 2022-05 | - |
dc.identifier.citation | Flórez ID1,2, Velásquez-Salazar P1, Martínez JC1, Linkins L3, Abdelkader W3, Iorio A3, Lavis J3, Patiño-Lugo DF1. COVID-19 living evidence synthesis #8 (version 11): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? Evidence and Deliberation Unit for Decision Making (UNED), University of Antioquia & Health Information Research Unit (HIRU), McMaster University, 9 May 2022. | en_US |
dc.identifier.uri | http://hdl.handle.net/11375/32316 | - |
dc.description.abstract | An in-depth synthesis of what is known, based on the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies), about the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern. | en_US |
dc.description.sponsorship | The development and continued updating of this living evidence synthesis has been funded by the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartofseries | LES 8.11; | - |
dc.subject | effectiveness | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | vaccines | en_US |
dc.subject | children | en_US |
dc.subject | adolescents | en_US |
dc.subject | variants | en_US |
dc.title | COVID-19 living evidence synthesis #8 (version 11): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? | en_US |
Appears in Collections: | Living evidence synthesis |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
COVID-19 Living Evidence Synthesis 8.11 - What is the effectiveness of available COVID-19 vaccines for children and adolescents, including variants of concern.pdf | 774.69 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License